Direct modulation of osteoblastic activity with estrogen.
Estrogens play an important but poorly understood role in the maintenance of skeletal mass. Whereas the mechanisms of estrogen action on bone may be complex, the finding that osteoblasts express estrogen receptors suggests that this class of hormones exerts direct effects on bone cells. To understand how estrogens regulate osteoblastic function, the physiologically active estrogen metabolite 17 beta-estradiol was tested to determine its effects on the well characterized murine osteoblastic cell-line MC3T3-E1. Experiments were designed to identify the effects of estrogen on osteoblastic activities associated with both the formation and the resorption of bone. Estrogen treatment coordinately increased DNA content and alkaline phosphatase activity in MC3T3-E1 cells as much as twofold. The stimulatory effect on alkaline phosphatase was stereospecific, dose-dependent between 0.1 and ten nanomolar, and dependent on the time in culture when the hormone was administered. The effect was also persistent, since alkaline phosphatase activity remained elevated for several days after withdrawal of the hormone. Estrogen increased the levels of messenger RNA for alkaline phosphatase and type-I collagen as well, and these effects also persisted after removal of the hormone. The levels of messenger RNA for osteopontin, another bone-matrix protein, were only slightly affected by estrogen. Finally, estrogen inhibited the activation of adenylate cyclase by three osteotropic agents known to stimulate the resorption of bone: parathyroid hormone, prostaglandin E2, and the beta-adrenergic agonist isoproterenol. Thus, estrogen promoted the expression of traits associated with the formation of bone while reducing cellular responsiveness to hormones that may trigger the resorption of bone.(ABSTRACT TRUNCATED AT 250 WORDS)
Majeska
R J
RJ
Department of Orthopaedics, Mount Sinai School of Medicine, New York, N.Y. 10029-6574.
Ryaby
J T
JT
Einhorn
T A
TA
D016475:3T3 Cells / Q000187:drug effects / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001862:Bone Resorption / Q000378:metabolism*; D003094:Collagen / Q000096:biosynthesis; D015232:Dinoprostone / Q000037:antagonists & inhibitors; D004958:Estradiol / Q000494:pharmacology*; D004967:Estrogens / Q000502:physiology*; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D051379:Mice; D010006:Osteoblasts / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000032:analysis
D004967:Estrogens; D010281:Parathyroid Hormone; D012333:RNA, Messenger; D004958:Estradiol; D003094:Collagen; D000469:Alkaline Phosphatase; D000262:Adenylyl Cyclases; D015232:Dinoprostone; D007545:Isoproterenol